Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude CLEE011X2110C : étude de phase 1b-2, évaluant la tolérance et l’efficacité d’un traitement associant ceritinib et LEE011, un inhibiteur de CDK4/6, chez des patients ayant un cancer du poumon non à petites cellules, ALK muté. [essai clos aux inclusions] https://kusajili.com:443/Trial/fj6Cc3HlM0W6_YWCLBstDg%24etude-clee011x2110c-etude-de-phase-1b-2-evaluant-la-tolerance-et-lefficacite-dun-traitement-associant-ceritinib-et-lee011-un-in
I have read and accept the terms of use of the site and the Privacy Policy
Send your message